Elevated serum levels of interleukin-18 discriminate Still’s disease from other autoinflammatory conditions: results from the European ImmunAID cohort
Our results show that IL-18 can discriminate Still's disease from other SAID, and free IL-18 levels may be relevant to assess response to therapy in these patients.
Authors
- Yvonne M. Mueller (ORCID: https://orcid.org/0000-0002-4654-7509)
- Cem Gabay (ORCID: https://orcid.org/0000-0001-6853-3063)
- Peter D. Katsikis (ORCID: https://orcid.org/0000-0001-7690-5218)
- Charlotte Girard (ORCID: https://orcid.org/0000-0002-4901-2059)
- Assunta Caruso
- Emiliana Rodriguez
Institutions
- University of Geneva (CH)
- Erasmus MC (NL)
- University Hospital of Geneva (CH)
- Geneva College (US)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- RMD Open
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1136/rmdopen-2024-005388
- Citations
- 5
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 4.03
Funders
- European Commission
- Université de Liège